_id

690f3b42ccc777a4e85d19a9

Ticker

CAPR

Name

Capricor Therapeutics Inc

Exchange

NASDAQ

Address

10865 Road to the Cure, San Diego, CA, United States, 92121

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.capricor.com

Description

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; and CAP-2003, and allogeneic cardiosphere-derived cells-exosomes, which is in preclinical trial to treat DMD. It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.

Last Close

27.18

Volume

1773098

Current Price

26.02

Change

-4.267844002943341

Last Updated

2025-11-29T11:08:50.196Z

Image

-

Ipo Date

2007-02-13T00:00:00.000Z

Market Cap

244593840

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.7175

Sentiment Sources

4

Rating

4.625

Target Price

20.7

Strong Buy

5

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

20359098

Gross Profit

-20359098

Operating Expenses

5924942

Operating Income

-26284040

Interest Expense

-

Pretax Income

-24570647

Net Income

-24570647

Eps

-0.5374609730377345

Dividends Per Share

-

Shares Outstanding

45718475

Income Tax Expense

-

EBITDA

-24075921

Operating Margin

-

Total Other Income Expense Net

1713393

Cash

19510383

Short Term Investments

79055588

Receivables

59167

Inventories

-

Total Current Assets

100951681

Property Plant Equipment

24997788

Total Assets

126438207

Payables

2719416

Short Term Debt

120094

Long Term Debt

-

Total Liabilities

42570952

Equity

83867255

Depreciation

246735000

Change In Working Capital

5660

Cash From Operations

-19688787

Capital Expenditures

4009422

Cash From Investing

-

Cash From Financing

6950

Net Change In Cash

-3730816

PE

-

PB

14.183536220662045

ROE

-29.297068325414966

ROA

-19.432929003809743

FCF

-23698209

Fcf Percent

-

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

2.5

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.3

Garp Investing Score

1.5

Growth Investing Score

0.5

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

2

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

20359098

Quarters > 0 > income Statement > gross Profit

-20359098

Quarters > 0 > income Statement > operating Expenses

5924942

Quarters > 0 > income Statement > operating Income

-26284040

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-24570647

Quarters > 0 > income Statement > net Income

-24570647

Quarters > 0 > income Statement > eps

-0.5374609730377345

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

45716151

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-24075921

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1713393

Quarters > 0 > balance Sheet > cash

19510383

Quarters > 0 > balance Sheet > short Term Investments

79055588

Quarters > 0 > balance Sheet > receivables

59167

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

100951681

Quarters > 0 > balance Sheet > property Plant Equipment

24997788

Quarters > 0 > balance Sheet > total Assets

126438207

Quarters > 0 > balance Sheet > payables

2719416

Quarters > 0 > balance Sheet > short Term Debt

120094

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

42570952

Quarters > 0 > balance Sheet > equity

83867255

Quarters > 0 > cash Flow > net Income

-24570647

Quarters > 0 > cash Flow > depreciation

246735000

Quarters > 0 > cash Flow > change In Working Capital

5660

Quarters > 0 > cash Flow > cash From Operations

-19688787

Quarters > 0 > cash Flow > capital Expenditures

4009422

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

6950

Quarters > 0 > cash Flow > net Change In Cash

-3730816

Quarters > 0 > ratios > PE

-0.5374609730377345

Quarters > 0 > ratios > PB

14.183536220662045

Quarters > 0 > ratios > ROE

-29.297068325414966

Quarters > 0 > ratios > ROA

-19.432929003809743

Quarters > 0 > ratios > FCF

-23698209

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

22047254

Quarters > 1 > income Statement > gross Profit

-22047254

Quarters > 1 > income Statement > operating Expenses

5671880

Quarters > 1 > income Statement > operating Income

-27719134

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-25910791

Quarters > 1 > income Statement > net Income

-25910791

Quarters > 1 > income Statement > eps

-0.5668632162749491

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

45709071

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-27232856

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1808343

Quarters > 1 > balance Sheet > cash

23241199

Quarters > 1 > balance Sheet > short Term Investments

99559482

Quarters > 1 > balance Sheet > receivables

59509

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

124126546

Quarters > 1 > balance Sheet > property Plant Equipment

8934463

Quarters > 1 > balance Sheet > total Assets

133569011

Quarters > 1 > balance Sheet > payables

4812356

Quarters > 1 > balance Sheet > short Term Debt

849505

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

28591955

Quarters > 1 > balance Sheet > equity

104977056

Quarters > 1 > cash Flow > net Income

-25910791

Quarters > 1 > cash Flow > depreciation

486278

Quarters > 1 > cash Flow > change In Working Capital

1671993

Quarters > 1 > cash Flow > cash From Operations

-20122211

Quarters > 1 > cash Flow > capital Expenditures

1449731

Quarters > 1 > cash Flow > cash From Investing

14549327

Quarters > 1 > cash Flow > cash From Financing

19580

Quarters > 1 > cash Flow > net Change In Cash

-5553304

Quarters > 1 > ratios > PE

-0.5668632162749491

Quarters > 1 > ratios > PB

11.329618801845614

Quarters > 1 > ratios > ROE

-24.682337252818368

Quarters > 1 > ratios > ROA

-19.39880426306368

Quarters > 1 > ratios > FCF

-21571942

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

18915572

Quarters > 2 > income Statement > gross Profit

-18915572

Quarters > 2 > income Statement > operating Expenses

6067376

Quarters > 2 > income Statement > operating Income

-24982948

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-24391594

Quarters > 2 > income Statement > net Income

-24391594

Quarters > 2 > income Statement > eps

-0.5344697065977168

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

45637000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-24577498

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

591354

Quarters > 2 > balance Sheet > cash

28794503

Quarters > 2 > balance Sheet > short Term Investments

115982893

Quarters > 2 > balance Sheet > receivables

59834

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

146250984

Quarters > 2 > balance Sheet > property Plant Equipment

7261615

Quarters > 2 > balance Sheet > total Assets

153765973

Quarters > 2 > balance Sheet > payables

5253636

Quarters > 2 > balance Sheet > short Term Debt

842101

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

26120506

Quarters > 2 > balance Sheet > equity

127645467

Quarters > 2 > cash Flow > net Income

-24391594

Quarters > 2 > cash Flow > depreciation

405450

Quarters > 2 > cash Flow > change In Working Capital

11679396

Quarters > 2 > cash Flow > cash From Operations

-6433520

Quarters > 2 > cash Flow > capital Expenditures

1140286

Quarters > 2 > cash Flow > cash From Investing

23890673

Quarters > 2 > cash Flow > cash From Financing

50354

Quarters > 2 > cash Flow > net Change In Cash

17507507

Quarters > 2 > ratios > PE

-0.5344697065977168

Quarters > 2 > ratios > PB

9.302913514351435

Quarters > 2 > ratios > ROE

-19.10886032482454

Quarters > 2 > ratios > ROA

-15.86280340449574

Quarters > 2 > ratios > FCF

-7573806

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

11130509

Quarters > 3 > income Statement > cost Of Revenue

14554936

Quarters > 3 > income Statement > gross Profit

-3424427

Quarters > 3 > income Statement > operating Expenses

4273414

Quarters > 3 > income Statement > operating Income

-7697841

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-7116603

Quarters > 3 > income Statement > net Income

-7116603

Quarters > 3 > income Statement > eps

-0.2020671512535847

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

35219000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-7322136

Quarters > 3 > income Statement > operating Margin

-69.15982907879594

Quarters > 3 > income Statement > total Other Income Expense Net

581238

Quarters > 3 > balance Sheet > cash

11286996

Quarters > 3 > balance Sheet > short Term Investments

140228881

Quarters > 3 > balance Sheet > receivables

10368489

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

163385267

Quarters > 3 > balance Sheet > property Plant Equipment

6874119

Quarters > 3 > balance Sheet > total Assets

170481086

Quarters > 3 > balance Sheet > payables

8181376

Quarters > 3 > balance Sheet > short Term Debt

834799

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

25018750

Quarters > 3 > balance Sheet > equity

145462336

Quarters > 3 > cash Flow > net Income

-7116603

Quarters > 3 > cash Flow > depreciation

375705

Quarters > 3 > cash Flow > change In Working Capital

-10447592

Quarters > 3 > cash Flow > cash From Operations

-14796329

Quarters > 3 > cash Flow > capital Expenditures

734722

Quarters > 3 > cash Flow > cash From Investing

-123381647

Quarters > 3 > cash Flow > cash From Financing

81087570

Quarters > 3 > cash Flow > net Change In Cash

-57090406

Quarters > 3 > ratios > PE

-0.2020671512535847

Quarters > 3 > ratios > PB

6.2999014397788855

Quarters > 3 > ratios > ROE

-4.892402525420739

Quarters > 3 > ratios > ROA

-4.1744237832928865

Quarters > 3 > ratios > FCF

-15531051

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-1.395358559073983

Quarters > 3 > health Score

26

Valuation > metrics > PE

-0.5374609730377345

Valuation > metrics > PB

14.183536220662045

Valuation > final Score

20

Valuation > verdict

372.8% Overvalued

Profitability > metrics > ROE

-29.297068325414966

Profitability > metrics > ROA

-24.339017197742354

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.5075992054348267

Risk > metrics > Interest Coverage

-53.12847919858669

Risk > final Score

-165

Risk > verdict

High

Liquidity > metrics > Current Ratio

35.552500607499184

Liquidity > metrics > Quick Ratio

35.552500607499184

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-24

Prev Risks > 1

-478

Prev Risks > 2

-90

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:18:49.097Z